FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to ophthalmology, and can be used for treating dry eye syndrome. That is ensured by administering an effective amount of a compound of formula I and/or II or its pharmaceutically acceptable salt form to a patient. What is also presented is a pharmaceutical composition.
EFFECT: group of inventions provides the effective treatment of dry eye syndrome in a patient by JAK path inhibition.
6 cl, 1 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR JAK PATH INHIBITION | 2011 |
|
RU2672100C2 |
| USE OF 2,4-DIAMINOPYRIMIDINES FOR TREATING ATHEROSCLEROSIS | 2009 |
|
RU2490015C2 |
| PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING DRY-EYE SYNDROME | 2008 |
|
RU2445098C2 |
| HETEROCYCLIC ANALOGUES OF PYRIMIDINES AS JAK INHIBITORS | 2012 |
|
RU2564419C1 |
| COMPOUNDS FOR TREATING/PREVENTING INFLAMMATORY OPHTHALMIC DISEASES | 2011 |
|
RU2582609C2 |
| AMINOPYRIMIDINYL DERIVATIVES | 2021 |
|
RU2817349C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT FOR PREVENTING OR TREATING DRY EYES SYNDROME | 2018 |
|
RU2722485C1 |
| PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | 2021 |
|
RU2819004C1 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND METHODS OF USING THEM | 2018 |
|
RU2769696C2 |
| PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES | 2009 |
|
RU2493157C2 |
